Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuo Toda

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Thescientificworldjournal|August 29, 2012
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazoneTakamasa Ohki, Akihiro Isogawa, Masahiko Iwamoto, et al.
Hepato-Gastroenterology|September 15, 2004
Early removal of bile duct stones in patients with acute biliary pancreatitis by endoscopic papillary balloon dilatationNobuo Toda, Keiji Saito, Ryouichi Wada, et al.
Hepato-Gastroenterology|December 31, 2003
Preserved function of the Oddi sphincter after endoscopic papillary balloon dilationHiroyuki Isayama, Yutaka Komatsu, Yusuke Inoue, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 24, 2006
Serum IgG4 concentrations in pancreatic and biliary diseasesKenji Hirano, Takao Kawabe, Natsuyo Yamamoto, et al.
Clinical Nephrology|February 27, 2013
AA amyloid nephropathy with predominant vascular deposition in Crohn's diseaseNoriaki Kurita, Nagaaki Kotera, Yu Ishimoto, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 1, 2015
Short-term prognostic factors for primary sclerosing cholangitisTakeo Watanabe, Kenji Hirano, Minoru Tada, et al.
Clinical Drug Investigation|July 14, 2016
Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver CirrhosisTomoharu Yamada, Takamasa Ohki, Yuki Hayata, et al.
Advances in Therapy|April 9, 2017
Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised IndexTakamasa Ohki, Mayuko Kondo, Yuki Karasawa, et al.
World Journal of Hepatology|July 4, 2015
Efficacy of tolvaptan in patients with refractory ascites in a clinical settingTakamasa Ohki, Koki Sato, Tomoharu Yamada, et al.
The American Journal of Gastroenterology|September 28, 2004
Pancreatic mass lesions associated with raised concentration of IgG4Kenji Hirano, Yutaka Komatsu, Natsuyo Yamamoto, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Thescientificworldjournal|August 29, 2012
The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazoneTakamasa Ohki, Akihiro Isogawa, Masahiko Iwamoto, et al.
Hepato-Gastroenterology|September 15, 2004
Early removal of bile duct stones in patients with acute biliary pancreatitis by endoscopic papillary balloon dilatationNobuo Toda, Keiji Saito, Ryouichi Wada, et al.
Hepato-Gastroenterology|December 31, 2003
Preserved function of the Oddi sphincter after endoscopic papillary balloon dilationHiroyuki Isayama, Yutaka Komatsu, Yusuke Inoue, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 24, 2006
Serum IgG4 concentrations in pancreatic and biliary diseasesKenji Hirano, Takao Kawabe, Natsuyo Yamamoto, et al.
Clinical Nephrology|February 27, 2013
AA amyloid nephropathy with predominant vascular deposition in Crohn's diseaseNoriaki Kurita, Nagaaki Kotera, Yu Ishimoto, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|April 1, 2015
Short-term prognostic factors for primary sclerosing cholangitisTakeo Watanabe, Kenji Hirano, Minoru Tada, et al.
Clinical Drug Investigation|July 14, 2016
Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver CirrhosisTomoharu Yamada, Takamasa Ohki, Yuki Hayata, et al.
Advances in Therapy|April 9, 2017
Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised IndexTakamasa Ohki, Mayuko Kondo, Yuki Karasawa, et al.
World Journal of Hepatology|July 4, 2015
Efficacy of tolvaptan in patients with refractory ascites in a clinical settingTakamasa Ohki, Koki Sato, Tomoharu Yamada, et al.
The American Journal of Gastroenterology|September 28, 2004
Pancreatic mass lesions associated with raised concentration of IgG4Kenji Hirano, Yutaka Komatsu, Natsuyo Yamamoto, et al.
Pageof 9